Rubin Tan
Impact in
-
- Neuroinflammation and Neurodegeneration Mechanisms
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Mitochondrial Function and Pathology 6
- Circular RNAs in diseases 4
- RNA modifications and cancer 4
-
- Pulmonary Hypertension Research and Treatments 7
- Co-authors
- Jinxiang Yuan (16 shared papers)Shijun Wang (2 shared papers)Qian Liu (2 shared papers)Jian Wu (1 shared paper)Fei Gao (1 shared paper)Hui Meng (1 shared paper)Meng Zhang (1 shared paper)Xin Liu (1 shared paper)
- Journals
- Signal Transduction and Targeted Therapy (2 papers)Oxidative Medicine and Cellular Longevity (2 papers)Frontiers in Cardiovascular Medicine (2 papers)American Journal of Physiology-Lung Cellular and Molecular Physiology (1 paper)Cellular & Molecular Biology Letters (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Rubin Tan
28 papers receiving 591 citations
Rubin Tan's Hit Papers
Peers
Comparison fields: 5 of 88
- Neurology 53
- Cancer Research 80
- Developmental Neuroscience 20
- Pulmonary and Respiratory Medicine 127
- Molecular Biology 249
Countries citing papers authored by Rubin Tan
This map shows the geographic impact of Rubin Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rubin Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rubin Tan more than expected).
Fields of papers citing papers by Rubin Tan
This network shows the impact of papers produced by Rubin Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rubin Tan. The network helps show where Rubin Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Rubin Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets Hit paper breakdown → | 2024 | 280 |
| 2 | 2020 | 55 | |
| 3 | 1970 | 31 | |
| 4 | 2020 | 27 | |
| 5 | 2023 | 21 | |
| 6 | 2022 | 20 | |
| 7 | 2013 | 20 | |
| 8 | Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Corresponding Therapeutic Strategies Hit paper breakdown → | 2025 | 19 |
| 9 | 2023 | 14 | |
| 10 | 2024 | 14 | |
| 11 | 2022 | 14 | |
| 12 | 2023 | 9 | |
| 13 | 2022 | 9 | |
| 14 | 2024 | 8 | |
| 15 | 2022 | 8 | |
| 16 | 2015 | 8 | |
| 17 | 2024 | 7 | |
| 18 | 2021 | 5 | |
| 19 | 2022 | 5 | |
| 20 | 2025 | 5 |
About Rubin Tan
Rubin Tan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Cardiology and Cardiovascular Medicine, having authored 29 papers that have together received 605 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (7 papers), Cancer-related molecular mechanisms research (6 papers), Mitochondrial Function and Pathology (6 papers), Circular RNAs in diseases (4 papers), RNA modifications and cancer (4 papers), MicroRNA in disease regulation (3 papers), Estrogen and related hormone effects (3 papers) and Metabolism and Genetic Disorders (2 papers). The work is most often cited by research in Neurology (53 citations), Cancer Research (80 citations), Developmental Neuroscience (20 citations), Pulmonary and Respiratory Medicine (127 citations) and Molecular Biology (249 citations). Rubin Tan has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Jinxiang Yuan, Shijun Wang, Qian Liu, Jian Wu, Fei Gao, Hui Meng, Meng Zhang, Xin Liu, Qinghua Hu and Qi Wu. Their work appears in journals such as Signal Transduction and Targeted Therapy, Oxidative Medicine and Cellular Longevity, Frontiers in Cardiovascular Medicine, American Journal of Physiology-Lung Cellular and Molecular Physiology and Cellular & Molecular Biology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.